Linagliptin Parent Nucleus Intermedia CAS 853029-57-9 Puritas ≥99.0% Factory
Manufacturer Supple Linagliptin et intermedia:
Linagliptin CAS 668270-12-0
Linagliptin Parent Nucleus Intermedia CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl) -3-methylxanthine CAS 666816-98-4
2-(Chloromethyl) -4-Methylquinazoline CAS 109113-72-6
(R) -3-(Boc-Amino) piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Nomen chemicum | 8-bromo-7-sed-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purinum-2,6-dione |
Synonyma | Linagliptin Parent Nucleus;Linagliptin medium F |
CAS Number | 853029-57-9 |
CATTUS Number | RF-PI502 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C20H17BrN6O2 |
M. Pondus | 453.29 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad lux Yellow pulveris |
Lepidium sativum | IR/HPLC |
Puritas | ≥99.0% |
Aquae (KF) | ≤1.0% |
Residere in Ignition | ≤0.50% |
Totalis immunditias | ≤1.0% |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedia pro Linagliptin (CAS: 668270-12-0) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
8-bromo-7-sed-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purinum-2,6-dione(CAS: 853029-57- 9) nucleus parentis Linagliptin est (CAS: 668270-12-0).Linagliptin (nomina Tradjenta et Trajetna) inhibitor est dipeptidyli peptidasi-4 (DPP-4), qui ab US FDA mense Maio 2011 probatus est ad tractationem Type 2 diabetae una cum victu et exercitatione.Linagliptin (BI-1356) descriptus est ut potentissimus selectivus, tardus rate et longus agendi inhibitoris DPP-4.Linagliptin ortum est ex optimizatione nisus xanthine-substructio DPP-4 inhibitores cum plumbo initiali ab expeditione HTS notati.